Novigenix announces the expansion of its senior leadership team with the appointment of Mr. Valentin Matillon as President and Chief Business Officer, reporting to the Board of Directors.
Mr. Matillon brings decades of experience in scaling unique business models, most recently as a senior member of the executive team at Sophia Genetics. As part of his mandate, he will lead commercial partnerships and scale up of the Novigenix LITOseek platform that delivers unique ImmunoTranscriptomic precision solutions to the pharma and biotech industries.
“I am thrilled to join Novigenix and I will work closely with our Board, Founders and Team to unleash Novigenix’s formidable growth potential, to steer the company through its next phases of development and to accelerate the positive impact of our technology on patients’ lives” – Valentin Matillon
Mr. Matillon joins Novigenix from Sophia Genetics where he served as CFO. He previously served at the Hobart Group as Senior Director of Finance. Before that Mr Matillon was Senior Director, Corporate Finance and Performance Management, at SITA. Earlier in his career he held finance & operations roles at Electronic Arts and Hewlett-Packard. Valentin holds a BBA degree from the Institute des Hautes Etudes Economiques et Commerciales de Paris, and an MSc in Technology and Management from the Ecole Centrale de Paris.